RUNX2 and myelodysplastic syndrome: After co-cultured with KG1a-TWIST1 or treatment with MDS/AML plasma, BMMSCs showed decreased RunX2 levels, increased PPAR-γ levels, and activation of the STAT1 signaling pathway (Fig. 6B&C).